Clinical Trials Directory

Trials / Completed

CompletedNCT03961022

Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice

Effects of Dietary Supplementation With ReWin(d) on the Recovery of Young Athletes Suffering From Delayed-Onset Muscle Soreness Induced by Acute Exercice: A Pilot Randomized, Double-blind, Placebo Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Natural Origins · Industry
Sex
Male
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

The study will assess the recovery and performance of young athletes suffering from muscle damage induced by physical exercise. Model by comparing the safety and efficacy of ReWin(d) supplemention during 4 weeks to placebo over 72 hours post exercice.

Detailed description

Double-blind, randomized, placebo controlled, parallel group, pilot safety and efficacy study. 40 healthy young male athetes were randomly assigned to the ReWin(d) or Placebo group. After 4 weeks supplementation (either 2 g daily of ReWin(d) capsules or placebo capsules). the participants were subjected to a 1 hour plyometric exercise session to induce DOMS. At 0 hours, 24 hours, 48 hours and 72 hours post exercise, the volunteers have been assessed to determine: (i) pain perception, (ii) fatigue rate, (iii) sport performance (effectiveness of a jump) and (iv) muscle damage and inflammation by I-R thermography and biomarkers

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolyherbal supplement: ReWin(d) vs PlaceboSupplementation during 4 weeks + 72 hours post acute exercice

Timeline

Start date
2018-10-22
Primary completion
2018-12-21
Completion
2018-12-21
First posted
2019-05-23
Last updated
2019-05-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03961022. Inclusion in this directory is not an endorsement.

Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice (NCT03961022) · Clinical Trials Directory